Bixiye
QP86-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Vtama® (tapinarof)
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1431 - 1440 ee natiijooyinka 3613
Bixiye
QP84-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Camzyos™ (mavacamten)
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2022
Bixiye
QP85-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Radicava® (edaravone)
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2022
Bixiye
QP83-22 MHCP Pharmacy Benefit Exclusion for Somatuline® Depot and Sandostatin® LAR Depot
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2022
Bixiye
Antidepressant Agents - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Acute Migraine Agents - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Acute Migraine Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP92R1-21 Update: Federal Employee Program Plans Migration of Dental Coverage to United Concordia Dental
Taariikhda uu dhaqangalayo Barnaamijka: Des 22, 2021
Bixiye
QP102-21 Preferred Genetic Laboratory Network
Taariikhda uu dhaqangalayo Barnaamijka: Des 22, 2021
Bixiye
QP103-21 Provider Appeals Delayed
Taariikhda uu dhaqangalayo Barnaamijka: Des 22, 2021